CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: expression and ability to bind immune complexes opsonized with complement from normal human serum

被引：0
|
作者：
Marzocchi-Machado, CM
Alves, CMOS
Azzolini, AECS
Polizello, ACM
Lucisano-Valim, YM
机构：
[1] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Chem & Phys, BR-14049 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Microbiol Immunol & Parasitol, BR-14049 Ribeirao Preto, SP, Brazil
来源：
MOLECULAR IMMUNOLOGY | 2001年 / 38卷 / 2-3期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
85
引用
收藏
页码：110 / 110
页数：1
相关论文
共 40 条
  • [1] CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: The influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum
    Marzocchi-Machado, CM
    Alves, CMOS
    Azzolini, AECS
    Polizello, ACM
    Carvalho, IF
    Lucisano-Valim, YM
    JOURNAL OF AUTOIMMUNITY, 2005, 25 (04) : 289 - 297
  • [2] CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus
    Kiss, E
    Csipo, I
    Cohen, JHM
    Reveil, B
    Kavai, M
    Szegedi, GY
    AUTOIMMUNITY, 1996, 25 (01) : 53 - 58
  • [3] Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes
    Nielsen, CH
    Rasmussen, JM
    Voss, A
    Junker, P
    Leslie, RGQ
    ARTHRITIS AND RHEUMATISM, 1998, 41 (04): : 613 - 622
  • [4] COMPLEMENT-OPSONIZED IGG ANTIBODY DSDNA IMMUNE-COMPLEXES BIND TO CR-1 CLUSTERS ON ISOLATED HUMAN ERYTHROCYTES
    TAYLOR, RP
    POCANIC, F
    REIST, C
    WRIGHT, EL
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 61 (02): : 143 - 160
  • [5] Erythrocytes from patients with systemic lupus erythematosus exhibit diminished capacity to inhibit uptake of complement-opsonized immune complexes and production of oxygen metabolites by neutrophils
    Nielsen, CH
    Rasmussen, JM
    Voss, A
    Junker, P
    Leslie, RGO
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1345 - 1345
  • [6] COMPLEMENT RECEPTOR (CR-1) DEFICIENCY IN ERYTHROCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    IIDA, K
    MORNAGHI, R
    NUSSENZWEIG, V
    JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (05): : 1427 - 1438
  • [7] Structural polymorphisms of complement receptor 1 (CR1) in systemic lupus erythematosus (SLE) patients and normal controls of three ethnic groups
    Moulds, JM
    Reveille, JD
    Arnett, FC
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (02): : 302 - 305
  • [8] COMPLEMENT RECEPTOR-1 (CR-1) ON ERYTHROCYTES OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    KAWAGUCHI, T
    YOKOTA, E
    NIHO, Y
    IMAMURA, T
    JAPANESE JOURNAL OF HUMAN GENETICS, 1988, 33 (04): : 451 - 460
  • [9] ABILITY OF COMPLEMENT TO RELEASE SYSTEMIC LUPUS-ERYTHEMATOSUS IMMUNE-COMPLEXES FROM CELL RECEPTORS
    MEDOF, ME
    SCARBOROUGH, D
    MILLER, G
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1981, 44 (02): : 416 - 425
  • [10] Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE)
    Csípö, I
    Kiss, E
    Soltész, P
    Antal-Szalmás, P
    Szegedi, G
    Cohen, JHM
    Taylor, RP
    Kávai, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 118 (03): : 458 - 464
1234